Clinical Trials Sponsored by Kowa Company, Ltd.

Total 476 results

Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

XLH

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

Aplastic Anemia

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Through QT/QTc Study of KW-6356

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KHK4827 in Subjects With Axial Spondyloarthritis (axSpA)

Axial Spondyloarthritis

Korea, Republic of, Taiwan, Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 4 Clinical Study of Brodalumab

Psoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic Erythroderma

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 2 Study of KHK4577

Atopic Dermatitis

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

Dermatitis, Atopic

Japan
Kyowa Kirin Co., Ltd.

Completed

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Type 2 Diabetes | Chronic Kidney Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) (JET-HCC)

Liver Cancer

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Terminated

Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

Solid Tumour

Singapore
Kyowa Kirin Co., Ltd.

Completed

A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus

Diabetes

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma

Peripheral T/NK-cell Lymphoma

Japan
Kyowa Kirin Co., Ltd.

Completed

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 (6500-004)

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia

X-linked Hypophosphatemic Rickets/Osteomalacia

Japan, Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KRN951 in Patients With Solid Tumors

Solid Tumors

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 3 Clinical Study of KHK4827

Psoriasis

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of OPC-262 in Patients With Type 2 Diabetes

Diabetes Type 2

Japan
Kyowa Kirin Co., Ltd.

Completed

Along-term Study of OPC-262 in Patients With Type 2 Diabetes

Diabetes, Type 2

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of OPC-262 in Patients With Type 2 Diabetes

Type 2 Diabetes

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 1 Study of ARQ 197 in Patients With Solid Tumors

Cancer
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KW-2246 in Patients With Cancer Pain

Pain | Cancer

Japan
Kyowa Kirin Co., Ltd.

Completed

A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor

Anemia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa (6002-009)

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease (MBD-5D)

End Stage Renal Disease | Hyperparathyroidism, Secondary

Japan
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

Healthy Volunteer

China
Mochida Pharmaceutical Company, Ltd.

Completed

Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia

Hypertriglyceridemia

Japan
Mochida Pharmaceutical Company, Ltd.

Completed

Utility of Presepsin in Distinguishing Between Sepsis and SIRS

Sepsis | SIRS

United States
a2 Milk Company Ltd.

Completed

Comparative A1 vs A2 Formula and Breast Feeding on Alimentation and Gastrointestinal Digestion for the Infant

Intestinal Absorption
a2 Milk Company Ltd.

Completed

Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People

Lactose Intolerance
a2 Milk Company Ltd.

Completed

Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior

Lactose Intolerance
Mochida Pharmaceutical Company, Ltd.

Completed

Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)

Steatohepatitis

United States, Puerto Rico
a2 Milk Company Ltd.

Completed

The Effects of a2 Infant Formula on Growth and Tolerance in Healthy Term Infants

Healthy

China
CJshine Technology Company Ltd.

Completed

To Study the Association Among Labor Pain and Physical Parameters in Laboring Pregnant Women

Labor Pain

Taiwan
a2 Milk Company Ltd.

Not yet recruiting

Investigate Effects of a2 Milk on Breastmilk Composition and Subsequent Infant Gut Health, Crying and Sleep Patterns in Healthy, Full-term Infants

Sleepiness | Digestive System Disease | Crying

China
Mochida Pharmaceutical Company, Ltd.

Completed

Efficacy of MND-2119 in Participants With Hypertriglyceridemia

Hypertriglyceridemia

Japan
a2 Milk Company Ltd.

Completed

A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Children

Gut Inflammation
Mochida Pharmaceutical Company, Ltd.

Completed

Study Evaluating Single Ascending Doses of MR1817

Adult

United Kingdom
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Withdrawn

A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
Kyowa Kirin, Inc.
AstraZeneca

Completed

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

Advanced Solid Tumors

United States
Kyowa Hakko Kirin UK, Ltd.

Completed

A Study of KW-3357 in Congenital Antithrombin Deficiency

Congenital Antithrombin Deficiency

France, Germany, Italy, Sweden, United Kingdom
Kyowa Hakko Bio Co., Ltd.

Recruiting

Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function

Gastrointestinal Diseases | Healthy

Singapore
Kyowa Kirin Pharmaceutical Development Ltd

Recruiting

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER) (PROSPER)

Mycosis Fungoides and Sézary Syndrome

Spain, United Kingdom, Netherlands, United States, Italy
Kyowa Kirin Pharmaceutical Development Ltd

Recruiting

A Study to Describe the Lived Experience of XLH for Adolescents at End of Skeletal Growth

X-Linked Hypophosphatemia

France, Netherlands, United Kingdom
Kyowa Kirin Pharmaceutical Development Ltd

Terminated

Naloxegol Health Outcome Post Authorisation Safety Study

Opioid Induced Constipation

Netherlands, United Kingdom

3

Subscribe